Combinational use of DNMT1 inhibitor and HDAC inhibitor is more effective on acute myeloid leukaemia and advanced Ewing's sarcoma (compared with single inhibitor used)39, 40. This evidence concerns the gene DNMT1 and Ewing sarcoma.